In short, our data demonstrated that HNRNP A1 is an important pro-tumorigenic factor in lung carcinogenesis and the therapeutic targeting of HNRNP A1/VRK1 may offer options for human lung cancer intervention. Here, VRK1 is linked to lung cancer.